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Congenital adrenal hyperplasia (CAH) describes a group of inherited autosomal recessive disorders characterized by enzyme
defects in the steroidogenic pathways that lead to the biosynthesis of cortisol, aldosterone, and androgens. Chronic excessive
adrenocorticotropic hormone (ACTH) stimulation may result in hyperplasia of ACTH-sensitive tissues in adrenal glands and
other sites such as the testes, causing testicular masses known as testicular adrenal rest tumors (TARTs). Leydig cell tumors (LCTs)
are make up a very small number of all testicular tumors and can be diﬃcult to distinguish from TARTs. This distinction is
interesting because LCTs and TARTs require diﬀerent therapeutic approaches. Hereby, we present an unusual case of a 19-year-old
patient with CAH due to 11β-hydroxylase deﬁciency, who presented with TARTs and an epididymal Leydig cell tumor.
1.Introduction
Congenital adrenal hyperplasia (CAH) describes a group
of inherited autosomal recessive disorders characterized by
enzyme defects in the steroidogenic pathways that lead
to the biosynthesis of cortisol, aldosterone, and andro-
gens.
Ninety percent of CAH cases have a defect in 21-alpha
hydroxylase enzyme [1]. Steroid 11β-hydroxylase deﬁciency
is the second most common cause of CAH, accounting for
less than 5% of cases. It is characterised by the overproduc-
tion of adrenal androgens and deoxycorticosterone, leading
tovirilizationoffemalefetuses,pseudoprecociouspubertyin
male infants, and hypertension with or without hypokalemia
in both genders [2].
The rising of adrenocorticotropic hormone (ACTH)
synthesis results in hyperplasia of ACTH-sensitive tissues in
adrenal glands and other sites such as the testes, causing
testicular masses known as testicular adrenal rest tumors
(TARTs) [3]. It is extremely diﬃcult to diﬀerentiate these
masses from Leydig cell tumors (LCTs), which are the most
common stromal testicular neoplasia [4, 5]. Both of these
tumors could lead to precocious puberty and testicular
masses [4]. Although the presentation of these two entities
is the same, therapeutic approach is completely diﬀerent.
LCTs require surgical treatment, while most cases of TARTs
respond to steroid suppressive therapy [4, 6].
Hereby, we present an unsual case of a 19-year-old
patient with CAH due to 11β-hydroxylase deﬁciency, who
presented with TARTs and an epididymal Leydig cell tumor.
2.CaseReport
The patient was a known case of CAH due to 11β-hydroxy-
lase deﬁciency since the age of 2-year old when he was evalu-
ated for growth acceleration, advanced bone age, virilization,2 Case Reports in Urology
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Figure 1: Longitudinal scrotal sonogram showing bilateral hypoechoic heterogeneous masses (RT: right testis, LT: left testis).
vomiting, diarrhea, generalized pigmentation, hyperten-
sion, and hypokalemia. Hormonal analyses were sugges-
tive for the diagnosis of 11β-hydroxylase deﬁciency: 17-
hydroxyprogesterone (17-OHP), 22ng/mL (normal range
1.4–2.5); androstenedione, 11.9ng/mL (normal range 0.9–
2.2); 11-deoxycortisol: 69.6ng/mL (normal <4) 8H Cortisol,
277ng/mL (normal range from 43 to 250ng/mL). His symp-
toms were controlled with 20mg of hydrocortisone. He was
irregular in followup and was not compliant with treatment.
The patient was born of a fourth degree consanguineous
marriage, and his family history was remarkable for early
neonatal deaths.
At the age of 19 years, he was hospitalized for severe
hypokalemia. On physical examination, he had a blood pres-
sure of 180/110mmHg, pulse rate of 70/min, temperature
of 37◦C, height of 163cm (−2 SD), and weight of 58kg
(10th–25th percentile). A systemic melanoderma was noted.
Genital examination demonstrated an enlarged right testis
measuring 6.5 by 5.5 by 4.5cm, and a 1.5-cm ﬁrm mass was
noted in its upper pole. The left testis was not palpable in
the scrotum or inguinal canal. The patient did not have any
testicular discomfort or pain. He had no gynecomastia.
He had normal biochemistry values and a poorly com-
pensated hormone proﬁle: ACTH 2500pg/mL (normal
range 10–50pg/mL); 17-OHP 17.5ng/mL; androstene-
dione 19.9ng/mL; dehydroepiandrosterone sulfate (DHEA-
S) 90μg/mL (normal range 35–441); plasma deoxycorticos-
terone (DOC) 9648ng/L (normal range: 40–170); testos-
terone 6.9ng/mL (normal range 1.7–7.8). Tumor markers
(α-fetoprotein, human chorionic gonadotropin, and lactate
dehydrogenase) were negative for malignancy. Semen analy-
sis showed severe oligo-astheno-teratospermia.
In testicular sonography, the right testis was present in
the normal position and was enlarged (6.8 × 5.7 × 4.5cm).
However, the left testis was atrophic (3.5 × 2.8 × 1.5cm)
and ectopic, near the common iliac vessels. In addition,
ultrasoundscanofrighttestisrevealedanhypoechoichetero-
geneous mass within the lower pole measuring 4.8 × 3.8cm
in diameter. The left testis contained three round-to-oval
hypoechoic heterogeneous lesions, 0.9–2.3cm in diameter,
located in the mediastinum testis (Figure 1). There was
also evidence of a 1.5cm hypoechoic mass of the right
epididymis. Power Doppler ultrasound showed normal
vascularity within the lesions.
Figure 2: T1-weighted magnetic resonance image of the pelvis
showing ectopic position of the left testis in front of the left
commoun iliac vessels.
The patient underwent a magnetic resonance imaging
(MRI) examination. Coronal images of the pelvis conﬁrmed
the ectopic position of the left testis, in front of the
left common iliac vessels (Figure 2). Bilateral testicular
masses were found. The lesions were isointense on T1-
weighted images and appeared hyperintense on T2-weighted
images (Figure 3). They showed a homogeneous enhance-
ment pattern. In addition, MRI study of the testis showed
right epididymal mass exhibiting the following features:
isointensity on T1-weighted images, marked enhancement
on postcontrast images, and hypointensity on T2-weighted
images with central areas of high signal intensity (Figure 4).
Four months after the administration of a stronger
suppressive medical treatment with exogenous steroids
(hydrocortisone 30mg daily), a decrease in the size of
right testis was noted (4cm × 3cm). Scrotal ultrasound
showed reduction in the size of the right testicular mass
(3.8 × 2.3cm) but did not show any reduction in the size
of the epididymal nodule. Hormone proﬁle still remained
poorly responsive to the compensation (17-OHP 8.1ng/mL;
testosterone: 9.1ng/mL and 11-deoxycortisol: 11.3ng/mL).
The patient was diagnosed as having bilateral testicular
adrenal rest tumor associated with a suspicious-appearing
mass in the right epididymis.
The patient underwent orchidopexy for the left ectopic
testis, as well as an excisional biopsy of the right epididymalCase Reports in Urology 3
Figure 3: Testicular T2-weighted images showingbilateral hyperin-
tense lesions with homogeneous enhancement.
Figure 4: Testicular T2-weighted images showing hypointense
lesion in the right epididymis, with central areas of high signal
intensity.
nodule. Bilateral biopsies of testicular parenchyma were also
taken during the operation.
Pathologic examination of the right testis revealed that
the epididymal nodule was well-circumscribed, encapsu-
lated, ﬁrm, yellow, and measuring 15mm in diameter.
Microscopy showed that this nodule was composed of
large polygonal cells with abundant eosinophilic, granu-
lar cytoplasm, and round, regular, vesicular nuclei with
prominent nucleoli. The tumor cells were separated by an
endocrinoid stroma. There was no evidence of inﬁltrating
margins, necrosis, calciﬁcation, nuclear atypia, or vascular
invasion. Both the lipochrome pigment and crystalloids
of Reinke’s were lacking (Figure 5). Immunohistochemistry
showed widespread vimentin and alpha inhibin positivity
(Figure 6). These features were consistent with epididymal
Leydig cell tumor.
Testicularbiopsyparenchymashowedadecreaseintubu-
lar diameter with peritubular ﬁbrosis and tubular hyalin-
ization. The lamina propria of the tubules was thickened.
ExtensiveLeydigcellhyperplasiawasseenintheinterstitium,
but no germ cells were present in seminiferous tubules.
Figure 5: High power view of the epididymal tumor showing nests
of polygonal cells with abundant granular eosinophilic cytoplasm
(H and E, ×400). No necrosis or Reinke’s crystal is seen.
Figure 6: Immunoperoxidase stain for vimentin showing strong
cytoplasmic positivity (IHC, ×100).
After 24 months of followup, the patient is in good gen-
eral health and continuing treatment with hydrocortisone.
Scrotal ultrasound at the last visit showed bilateral multiple
nodulesstableinsize.Thepatientisnowpreparingforpartial
orchiectomy.
3. Discussion
CAH patients with testicular enlargement present a diﬃcult
diagnostic dilemma. Tumors of adrenal rest tissue, LCTs,
and Leydig cell hyperplasia are the primary etiologic con-
siderations [7]. In this report, we describe a patient with
CAH due to 11β-hydroxylase deﬁciency, presenting bilateral
TARTs and epididymal Leydig cell tumor. To the best of
our knowledge, such association has not been previously
reported.
TARTs are one of the known complications of CAH.
Theirreportedprevalenceisuptoto94%ofCAHadults,and
they may already appear during childhood [8]. They proba-
bly develop from ectopic remnants of intratesticular adrenal
tissue stimulated by ACTH hypersecretion [6]. Such tumors
are always benign but compress the seminiferous tubules
and lead to obstructive azoospermia, peritubular ﬁbrosis,
and irreversible damage to the surrounding testicular tissue,
resulting in infertility. They may also have a paracrine eﬀect4 Case Reports in Urology
via local steroid production which may be toxic to the Leydig
cells and/or germ cells [6, 9].
LCTs are rare testicular tumors of the male gonadal
interstitium,accountingfor1–3%ofalltesticularneoplasms.
These tumors are most common in prepubertal boys aged 5–
10 years and in adults aged 30–60 years [10]. Approximately
10% of LCTs are malignant, and this variant occurs exclu-
sively in adults [4, 11].
The etiology of LCTs remains unknown. Unlike germ cell
testicular tumors, Leydig cell neoplasms are not associated
with cryptorchidism. It is thought that an endocrine role
may contribute to the development of these tumors. The
disruption of the hypothalamic-pituitary testicular axis
leading to excessive stimulation of Leydig cells by excess
luteinizing hormone may induce Leydig cells oncogenesis
[12]. High estrogen levels also could play a role in the
neoplastic transformation of Leydig cells [13].
LCTs are frequently hormonally active, leading to fem-
inizing or virilizing syndromes. These tumors were once
managed primarily with radical orchiectomy. However, the
experience with conservative procedures has been growing
[14].
The occurrence of leydigioma in CAH patients is excep-
tional, and only six cases of Leydig-cell tumour associated
with CAH have been reported so far [3, 15–18]. These
reports have raised concerns about the distinction of LCT
from TARTs. Such distinction is interesting, given that there
is a diﬀerent approach to each pathology; LCTs require
surgical treatment, while most cases of TARTs respond
to medical treatment [4, 6]. To diﬀerentiate between the
two syndromes, some features have been reported, even
if there are no pathognomonic characteristics [19]. TARTs
are usually bilateral, painful, and found typically adjacent
to hilum of the testis. Indeed, they generally regress with
corticosteroid replacement [4]. In contrast, LCTs are usually
unilateral, painless, unresponsive to ACTH suppression
therapy, and located in the interstitial tissue of testis next to
the seminiferous tubules. There are no biochemical markers
enabling diﬀerentiation between the 2 syndromes although
high level of plasma testosterone may be suggestive of LCTs
[20]. Histologically, there is a strict resemblance between the
Leydig cell tumor and adrenocortical cells typical of CAH
testicular nodules. Cytoplasmic rod-like crystalloids called
Reinke crystals are characteristic of the Leydig cell tumor,
but they are not positive in 60% of patients with LCT [21].
In addition, Inhibin A could be a sensitive and a speciﬁc
immunohistochemical marker for LCTs [22].
In our patient, unilaterality, the lack of response to glu-
cocorticoid therapy and immunohistological features were
suggestiveofthediagnosisofaLeydigcelltumor.Inaddition,
imaging characteristics argue also for this diagnosis. Indeed,
as seen in our patient, LCTs are typically isointense on T1-
weighted, -showed enhancement and are hypointense on T2
weighted with central areas of increased signal [23].
4. Conclusion
Our report illustrates an unusual association of epididymal
Leydig cell tumor with TARTs in a patient with CAH due
to 11β-hydroxylase deﬁciency. The distinction between these
t w ot u m o r si so f t e nd i ﬃcult, but interesting as treatment
modalities are diﬀerent. CAH patients with testicular tumor
need cautious approach during investigations to avoid
inappropriate orchiectomies.
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